Paroxetine Tablet, Film Coated
Product Images NDC 68788-8829

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 68788-8829). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Paroxetine Tab Usp 10mg (Image 01)

This document contains important information regarding Paroxetine tablets, which is a generic form of Paxil. It provides details about the dosage, composition, manufacturer, and storage instructions for the tablets. It includes a warning to store the medication at controlled room temperature to ensure its effectiveness. The tablets are described as capsule-shaped, brown in color, scored, and are imprinted with the code 710/HH. The text warns against transferring the drug to anyone other than the prescribed patient, as it is prohibited by federal law.*

FDA Label Image

Picture1 (Image 05)

FDA Label Image

Figure (Image 06)

This appears to be a list of interacting drugs and their respective dosages. The list includes Pimozide, Desipramine, Propranolol, Digoxin, and Phenytoin with their specific dosages mentioned. It also references fold change and 90% confidence level. The text seems to be related to comparing the change relative to a reference value.*

FDA Label Image

Figure2 (Image 07)

This information appears to discuss a list of interacting drugs with their prescribed dosages and frequencies. Additionally, it seems to mention fold change and a confidence interval of 90% in relation to a reference value. The document might be detailing the impact of these drugs on a specific aspect of health or pharmacokinetics.*

FDA Label Image

Figure 3 (Image 08)

This indicates a population description outlining different categories such as Renal Impairment (Mild, Moderate, Severe), Hepatic Impairment, Age (>65 years) with corresponding dosage, Gender (Males), and pharmacokinetic parameters (PK) like Crmax, AUC, Cmax, Crmin, and their fold change and 90% confidence level. The text also mentions a change relative to the reference of 50.0.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.